| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8223937 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 7 Pages |
Abstract
In patients with KRAS wild-type locally advanced rectal cancer, the addition of cetuximab to the chemoradiation with irinotecan plus capecitabine regimen was not associated with improved clinical outcome compared with chemoradiation without cetuximab.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Sun Young MD, Eun Kyung RN, Hyun Yang PhD, Ji Yeon MD, Yong Sang MD, Dae Yong MD, PhD, Tae Won MD, PhD, Jee Hyun MD, PhD, Seock-Ah MD, PhD, Kyung Hae MD, PhD, Hee Jin MD, PhD,